This study aimed to evaluate the levels of FGF23, Klotho, IL-6, IL-10, and Mstn in relation to subjects without comorbidities in stable kidney transplant recipients receiving triple immunosuppressive therapy. This evidence concerns the gene KL and medical procedure.